Filling the need for trusted information on national health issues…

Trending on kff Subsidies Marketplaces Enrollment

Intellectual Property and Trade

  • your selections
Clear Search

Filter Results

date

Tags

  • results
South Africa, Drug Companies Spar Over Intellectual Property Laws

Reuters: South Africa slams Big Pharma in generic drugs row “South Africa on Friday slammed global drug firms over a covert campaign against its planned overhaul of intellectual property laws to favor cheaper generic drugs, accusing pharmaceutical companies of a ‘satanic’ plot to commit ‘genocide.’ … South Africa is in…

‘Science Speaks’ Blog Examines Proposal Against South Africa’s Draft IP Policy

The Center for Global Health Policy’s blog “Science Speaks” reports on a proposal prepared by U.S.-based PhRMA (Pharmaceutical Research and Manufacturers of America) and the South Africa-based IPASA (Innovative Pharmaceutical Association South Africa) in response to the South African government’s Draft National Policy on Intellectual Property (IP). The “proposal says…

Sharp Divide In Support Of South Africa’s Intellectual Property Reforms

Times of India: Access to medicines issue splits the world, developing vs developed “The recently concluded meeting of the World Health Organization’s executive board saw a sharp divide between developing and developed countries on the issue of South Africa’s reforms of its intellectual property laws to enable affordable access to…

Lawmakers ‘Falling Short’ In Improving Access To Medicines Worldwide

“In his State of the Union address last week, President Obama nominally reaffirmed his commitment to universal health care, citing the success of the Affordable Care Act. Despite his dedication to free and fair medical services for Americans, he failed to comment on the essential life-saving global medicine funding programs…

Blog Highlights Debate Around South Africa’s Delayed Patent Reforms

The Center for Global Health Policy’s “Science Speaks” blog discusses details on “Pharmagate,” a plan with the aim “to derail proposed patent reforms in South Africa, [however,] those involved indicated that the plan, dubbed ‘genocidal’ by South Africa Health Minister Aaron Motsoaledi, was the product of a misunderstanding…” (Barton, 2/11).

Australia Stands With S. Africa In Defense Of TRIPS Flexibilities

Huffington Post: Unlikely Allies Sandeep Kishore, chair of the Advisory Council of the Young Professionals Chronic Disease Network, and Kavitha Kolappa, a psychiatry resident at Massachusetts General/McLean Program “The recent Executive Board proceedings of the World Health Organization (January 20-25, 2014) provided new ground for unlikely allies South Africa and…

U.S. Expresses Concern Over India’s Proposal To Allow More Generic Drug Production

Reuters: U.S. fears for patents on next-generation drugs in India “The United States on Thursday voiced concern over protection of patents on safer and more effective next-generation medicines in India amid fears that authorities are considering allowing more Indian firms to make new varieties of cheap generic drugs still on…

Australia Asks Opponents To Stop Stalling WTO Tobacco Packaging Case

Reuters: Australia demands opponents stop stalling WTO tobacco case “Australia asked five countries challenging its tobacco policies on Wednesday to stop delaying the progress of their cases at the World Trade Organization and took the unusual step of speeding up one of the complaints against itself. … Australia hopes the…

TPP Would Limit Countries’ Abilities To Make, Purchase Low-Cost Generic Medicines

Huffington Post: TPP: Still a Terrible Deal for Poor People’s Health Manica Balasegaram, executive director of Médecins Sans Frontières’ Access Campaign “…The ability to manufacture and/or purchase low-cost generic medicines requires maintaining a balance in a country’s patent system between monopoly protection and public health. Yet, the [Trans-Pacific Partnership (TPP)]…